Kras Mutant Solid Tumors clinical trials

Explore recruiting kras mutant solid tumors clinical trials.

Recruiting kras mutant solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kras Mutant Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-372 as a Single Agent and in Combination with Other Anti-Tumor Agents, in Patients with Advanced KRAS Mutant Solid Tumors

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study of the PAN-KRAS inhibitor LY4066434 in participants with KRAS mutant solid tumors.

Belgium, Spain, Germany, France, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Kras Mutant Solid Tumors trials by city

Kras Mutant Solid Tumors in Toronto Kras Mutant Solid Tumors in Vancouver Kras Mutant Solid Tumors in Montreal Kras Mutant Solid Tumors in Calgary Kras Mutant Solid Tumors in Edmonton Kras Mutant Solid Tumors in Ottawa Kras Mutant Solid Tumors in Winnipeg Kras Mutant Solid Tumors in Quebec City Kras Mutant Solid Tumors in Hamilton Kras Mutant Solid Tumors in Kitchener Kras Mutant Solid Tumors in London Kras Mutant Solid Tumors in Halifax Kras Mutant Solid Tumors in New York Kras Mutant Solid Tumors in Los Angeles Kras Mutant Solid Tumors in Chicago Kras Mutant Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease